This study analyzed the expression of PD-L1 in different ICI clusters and found that the highest expression of PD-L1 in ICI cluster C patients with poor prognosis, and PD-1/L1 has been identified as a possible target for immunotherapy in MSI-H/dMMR colon cancer [20, 40]. Here, CD274 is linked to malignant colon neoplasm.